Tracing Spatiotemporal T790M Heterogeneity in Patients with EGFR-Mutant Advanced NSCLC after Acquired Resistance to EGFR TKIs

被引：0
|
作者：
Zhang, Yi-Chen
Pi, Can
Ke, E-E
Chen, Zhi-Hong
Su, Jian
Dong, Zhong-Yi
Xu, Chong-Rui
Tu, Hai-Yan
Yan, Hong-Hong
Zhong, Wen-Zhao
Yang, Jin-Ji
Zhang, Xu-Chao
Wu, Yi Long
Zhou, Qing
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] GGH, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Acquired resistance; EGFR TKIs; spatiotemporal heterogeneity; T790M;
D O I：
10.1016/j.jtho.2016.11.1762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-095
引用
收藏
页码：S1249 / S1249
页数：1
相关论文
共 50 条
  • [1] Tracking spatiotemporal T790M heterogeneity in patients with EGFR-mutant advanced NSCLC after acquired resistance to EGFR TKIs
    Zhang, Y-C.
    Pi, C.
    Ke, E-E.
    Chen, Z-H.
    Su, J.
    Dong, Z-Y.
    Xu, C-R.
    Yan, H-H.
    Tu, H-Y.
    Zhong, W-Z.
    Zhang, X-C.
    Yang, J-J.
    Yang, X-N.
    Zhou, Q.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI Resistance
    Zhang, Yidan
    Xu, Yingqi
    Xu, Jianlin
    Zhong, Hua
    Xia, Jinjing
    Zhong, Runbo
    CANCER SCIENCE, 2024,
  • [3] Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non-Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Kaji, Reiko
    Masago, Katsuhiro
    Fujita, Shiro
    Imai, Yukihiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) : 1553 - 1559
  • [4] Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients
    Remon, Jordi
    Caramella, Caroline
    Joelet, Cecile
    Lacroix, Ludovic
    Lawson, Andrew
    Smalley, Sarah
    Howarth, Karen
    Gale, Davina
    Rosenfeld, Nitzan
    Green, Emma
    Plagnol, Vincent
    Planchard, David
    Bluthgen, Maria
    Gazzah, Annas
    Pannet, Chloe
    Nicotra, Claudio
    Soria, Jean-Charles
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1254 - S1255
  • [5] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs.
    Oya, Yuko
    Yoshida, Tatsuya
    Tanaka, Kosuke
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Hida, Toyoaki
    Yatabe, Yasushi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs
    Oya, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S622 - S622
  • [7] Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung Cancer
    Ichihara, Eiki
    Lovly, Christine M.
    CANCER DISCOVERY, 2015, 5 (07) : 694 - 696
  • [8] Predictive factors and prognostic significance of T790M mutation in patients with EGFR-mutant NSCLC
    Hwang, Ji An
    Choi, Chang-Min
    Lee, Jae Cheol
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [9] A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
    Lu, S.
    Zhang, Y.
    Zhang, G.
    Zhou, J.
    Cang, S.
    Cheng, Y.
    Wu, G.
    Cao, P.
    Lv, D.
    Jian, H.
    Chen, C.
    Jin, X.
    Tian, P.
    Wang, K.
    Jiang, G.
    Chen, G.
    Chen, Q.
    Zhao, H.
    Ding, C.
    Guo, R.
    Sun, G.
    Wang, B.
    Jiang, L.
    Liu, Z.
    Fang, J.
    Yang, J.
    Zhuang, W.
    Liu, Y.
    Zhang, J.
    Pan, Y.
    Chen, J.
    Yu, Q.
    Zhao, M.
    Cui, J.
    Li, D.
    Yi, T.
    Yu, Z.
    Yang, Y.
    Zhang, Y.
    Zhi, X.
    Huang, Y.
    Wu, R.
    Chen, L.
    Zang, A.
    Cao, L.
    Li, Q.
    Li, X.
    Song, Y.
    Wang, D.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S469 - S469
  • [10] Activation of IGF1R confers acquired resistance to osimertinib in EGFR-mutant NSCLC with T790M mutation
    Hayakawa, Daisuke
    Takahashi, Fumiyuki
    Tajima, Ken
    Mitsuishi, Yoichiro
    Nakamura, Ikuko
    Winardi, Wira
    Shirai, Yukina
    Miyashita, Yosuke
    Yamada, Tomoko
    Miura, Keita
    Torasawa, Masahiro
    Matsuda, Hironari
    Asao, Tetsuhiko
    Shukuya, Takehito
    Takahashi, Kazuhisa
    CANCER SCIENCE, 2022, 113 : 1060 - 1060
12345